Bahi-an, Jeffrey T.

HRN: 05-16-75  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/26/2022
CEFTRIAXONE 1G (VIAL)
09/26/2022
10/02/2022
IV
2 Grams
Q 24 Hrs
Cap- Mr
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: